Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Curr Mol Pharmacol ; 14(2): 234-244, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32368990

RESUMEN

BACKGROUND: Mutations in the brain-derived neurotrophic factor (BDNF) gene and its receptor, tyrosine receptor kinase B (TrkB), have been reported to cause severe obesity in rodents. Our previous study demonstrated that the oral administration of 5% Eucommia leaf extract (ELE) or ELE aroma treatment (ELE aroma) produced anti-obesity effects. OBJECTIVE: In this study, we investigated the effects of ELE on glycolysis and lipid metabolism in male Sprague-Dawley rats, as well as the effects of ELE on BDNF in rat hypothalamus. METHODS AND RESULTS: A significant reduction and a reduction tendency in the respiratory quotient were observed in association with 5% ELE and ELE aroma treatment, respectively. Furthermore, RT-qPCR results showed significant increases in Cpt2, Acad, Complex II, and Complex V mRNA levels in the liver with both treatments. In addition, in rat hypothalamus, significant elevations in BDNF, Akt, PLCγ proteins and CREB phosphorylation were observed in the 5% ELE group and the ELE aroma group. Furthermore, the Ras protein was significantly increased in the ELE aroma group. On the other hand, significant dephosphorylation of ERK1/2 was observed by the western blotting in the 5% ELE group and the ELE aroma group. CONCLUSION: These findings suggest that the ELE treatment enhances the lipid metabolism and increases the aerobic glycolytic pathway, while ELE-induced BDNF may affect such energy regulation. Therefore, ELE has the possibility to control metabolic syndrome.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/química , Eucommiaceae/química , Extractos Vegetales/química , Hojas de la Planta/química , Animales , Factor Neurotrófico Derivado del Encéfalo/farmacología , Glucólisis , Humanos , Hipotálamo , Metabolismo de los Lípidos , Hígado , Sistema de Señalización de MAP Quinasas , Masculino , Ratas , Ratas Sprague-Dawley
2.
J Neuroimmunol ; 129(1-2): 43-50, 2002 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12161019

RESUMEN

Leukemia inhibitory factor (LIF) is a cytokine involved in the survival and differentiation of the neural cells in the central and peripheral nervous systems. In the present study, we examined the effects of various neurotransmitter receptor agonists on LIF mRNA expression in cultured rat astrocytes, microglia and neurons to elucidate the cell types producing LIF and to clarify the neurotransmitter(s) regulating the mRNA expression. The results demonstrated that the expression of LIF mRNA was intensely induced by ATP in the cultured astrocytes. Experiments using ATP, UTP and related compounds showed the involvement of P2Y2 and P2Y4 purinoceptors in the expression induced by ATP.


Asunto(s)
Adenosina Trifosfato/metabolismo , Astrocitos/metabolismo , Sistema Nervioso Central/crecimiento & desarrollo , Inhibidores de Crecimiento/genética , Interleucina-6 , Linfocinas/genética , Fosfato de Piridoxal/análogos & derivados , ARN Mensajero/metabolismo , Receptores de Neurotransmisores/metabolismo , Receptores Purinérgicos/metabolismo , Adenosina Difosfato/metabolismo , Adenosina Difosfato/farmacología , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/farmacología , Animales , Animales Recién Nacidos , Astrocitos/citología , Astrocitos/efectos de los fármacos , Células Cultivadas , Sistema Nervioso Central/citología , Sistema Nervioso Central/metabolismo , Relación Dosis-Respuesta a Droga , Feto , Inhibidores de Crecimiento/metabolismo , Factor Inhibidor de Leucemia , Linfocinas/metabolismo , Microglía/citología , Microglía/efectos de los fármacos , Microglía/metabolismo , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neurotransmisores/metabolismo , Neurotransmisores/farmacología , Fosfato de Piridoxal/farmacología , ARN Mensajero/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Receptores de Neurotransmisores/agonistas , Receptores Purinérgicos/efectos de los fármacos , Receptores Purinérgicos P2/efectos de los fármacos , Receptores Purinérgicos P2/metabolismo , Receptores Purinérgicos P2Y2 , Suramina/farmacología , Uridina Trifosfato/metabolismo , Uridina Trifosfato/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA